Health care stocks leaned lower premarket Monday as the Health Care Select Sector SPDR Fund (XLV) was down 0.5% and the iShares Biotechnology ETF (IBB) declined by 1.6% recently.
Owens & Minor (OMI) shares fell past 1% after the company said it expects to record a Q4 non-cash goodwill impairment charge in its Apria division of about $310 million, or around a $4 net loss per share. The company also reported preliminary Q4 revenue that missed market expectations.
Becton Dickinson (BDX) is considering a potential separation of its life sciences division, according to media reports. Becton Dickinson shares were up over 0.5% pre-bell.
GH Research (GHRS) shares rose past 89% after the company said a phase 2b clinical trial of GH001 for patients with treatment-resistant depression met its primary endpoint.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。